Sushil Patel is on the board of Revolution Medicines, Inc. and Chief Strategy Officer of Replimune Group, Inc.
Dr. Patel previously held the position of Vice President-Franchise & Head-Oncology at Genentech, Inc.
Dr. Patel received a graduate degree from Imperial College London, a doctorate from the University of London and an undergraduate degree from the University of Warwick.
|06/08/2023||5,200||Award at $0 per share.||0|
|06/16/2022||10,500||Award at $0 per share.||0|